Skip to main content
OpenTrials
Completed

NCT Number: NCT01415258

Screening for Vulnerability in the Elderly Supported at the Oscar Lambret Centre

The objective of this study is to uncover the prevalence of vulnerability among patients aged ≥ 70 coming to the medical oncology division of the Oscar Lambret Centre, according to the short screening test Vulnerable Elders Survey 13 (VES-13).

The objective is to better understand the value of routine screening of patients before the consultation, it was proposed as a secondary objective of this study to assess the correlation between the identification of the vulnerability in the screening test VES-13 and the identification made by the clinician during the consultation. The correlation between VES-13 and opinion of the clinician for three categories of patients (self - intermediate - fragile) will also be studied.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Solid Tumor Neoplasms

Age range

70 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Oscar Lambret Anti-Cancer Centre

Lille, 59020, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patient aged ≥ 70
  • coming for a first visit, whatever the purpose and the disease stage

Exclusion criteria

  • neglect or refusal to answer to the VES-13 test

Treatment and study plan

Primary outcomes

  1. To assess the Vulnerable Elders Survey score (VES-13)

    Time frame: Within 3 months after recruitment

    A patient is identified vulnerable if the score is ≥ 3

Secondary outcomes

  1. To assess the correlation between the VES-13 score and the vulnerability judged by a clinical expert

    Time frame: Within 3 months after recruitment

    A patient will be identified as vulnerable if he/she belongs to the "intermediate" or "frail" category. The Kappa coefficient of agreement will be used to correlate the VES-13 score and clinical observations.

  2. To measure the muscle strength using the grip strength test

    Time frame: Within 3 months after recruitment

    Hand Dynamometer Range values : 0-90

Sponsors and collaborators

Lead sponsor

Centre Oscar Lambret

Other

Collaborators

  • Hôpital Gériatrique Les Bateliers, CHRU Lille

Registry information

Acronym: VULNERABILITE

Important dates

Study start
2011
Primary completion
2011
Study completion
2012
First posted
Aug 11, 2011
Registry last updated
Mar 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.